Tag: Eli Lilly

Post approval from the Drugs Controller General of India, the drug will be available for treatment of adults with moderate-to-severe plaque psoriasis

Vineet will take over from Luca Visini who served as Managing Director of the company in India from February 2018 to December 2021

Cipla will leverage its capabilities and robust distribution strengths to engage healthcare professionals and expand access to these treatments for patients who need them...................

Luca Visini, Managing Director, Eli Lilly & Company India shares his views on a variety of questions related to the company's operations in an exclusive interaction with BioVoice....................

Mentioned Luca Visini, Managing Director, Eli Lilly & Company India in an exclusive interaction with BioVoice where he outlined the goals of his company driven by innovation including pursual of new drug development and working towards medicines reaching people at large through different channels.....................

The latest failure of three anti-obesity drugs to provide the anticipated results could lead to the companies taking a cautious approach while investing to develop further drugs in the area.............

The product contains 200 U/mL rapid acting insulin, delivers the same benefits of Humalog 100U/mL in half the volume and operates with a much smoother glide force.....

Mentioned Mr Edgard A. Olaizola who serves as the Managing Director of Eli Lilly and Company (India) since September 1, 2013. Mr Olaizola has with him over 13 years of diversified experience in Lilly.....

Lupin to market Lilly’s rapid-acting Insulin analog Lispro under the brand name Eglucent®.......

QuintilesIMS has formed new collaboration with Bristol-Myers Squibb, Lilly, Merck KGaA, Darmstadt, Germany, and Pfizer to addresses information gaps on actual utilization of anti-cancer therapies....